Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.94 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.94 |
| ▸ | LMNA | P02545 | 5/20 | 0.94 |
| ▸ | MEN1 | O00255 | 5/20 | 0.94 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.94 |
| ▸ | NPC1 | O15118 | 4/20 | 0.94 |
| ▸ | HTT | P42858 | 4/20 | 0.94 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.94 |
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29354111 | 0.97 | MAPT (1.00) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL574042 | 0.97 | MAPT (1.00) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL131175 | 0.97 | MAPT (1.00) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL27424715 | 0.94 | MAPT (0.94) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL29710671 | 0.94 | MAPT (0.94) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL27424712 | 0.94 | MAPT (0.94) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL6707273 | 0.94 | MAPT (0.94) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL28553431 | 0.87 | MEN1 (0.80) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL4670227 | 0.85 | MAPT (0.76) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL16341089 | 0.85 | MAPT (0.76) | MAPTSMN1; SMN2LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9199924-B2 | Process for the preparation of urethanes | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-01 | — | — | US | disclosed |
| EP-2603319-B1 | PROCESS FOR THE PREPARATION OF URETHANS | BAYER IP GMBH (DE) | 2014-10-22 | — | — | EP | disclosed |
| US-20130303740-A1 | METHOD FOR PRODUCING URETHANES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-11-14 | — | — | US | disclosed |
| EP-2603319-A1 | METHOD FOR PRODUCING URETHANES | Bayer Intellectual Property GmbH (DE) | 2013-06-19 | — | — | EP | disclosed |
| WO-2012020028-A1 | METHOD FOR PRODUCING URETHANES | BAYER MATERIALSCIENCE AG (DE) | 2012-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303740-A1 | METHOD FOR PRODUCING URETHANES | SOD1, AOC2, DUOX2 | MAPT 598/4885SMN1; SMN2 2152/4885LMNA 1462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.